Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
NewCo’s pipeline includes five investigational medicines
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Subscribe To Our Newsletter & Stay Updated
